| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 989.00M | 6.77B | 1.29B | 1.26B | 1.28B | 1.27B |
| Gross Profit | 989.00M | 6.35B | 1.29B | 1.26B | 1.17B | 1.46B |
| EBITDA | 379.00M | 6.52B | 1.14B | 1.17B | 1.49B | 1.31B |
| Net Income | 6.16B | 6.12B | 6.00B | 5.65B | 6.14B | 6.13B |
Balance Sheet | ||||||
| Total Assets | 97.10B | 94.08B | 95.70B | 94.53B | 94.30B | 93.55B |
| Cash, Cash Equivalents and Short-Term Investments | 1.56B | 2.73B | 4.20B | 5.89B | 4.61B | 5.43B |
| Total Debt | 3.77B | 2.51B | 3.10B | 3.24B | 3.44B | 3.64B |
| Total Liabilities | 8.18B | 7.00B | 6.95B | 7.67B | 7.54B | 8.79B |
| Stockholders Equity | 88.92B | 87.08B | 88.75B | 86.86B | 86.77B | 84.77B |
Cash Flow | ||||||
| Free Cash Flow | 2.89B | 941.00M | 1.14B | 771.00M | 939.00M | 960.00M |
| Operating Cash Flow | 2.89B | 941.00M | 1.14B | 772.00M | 939.00M | 962.00M |
| Investing Cash Flow | 144.00M | 5.69B | 4.61B | 4.01B | 5.93B | 5.13B |
| Financing Cash Flow | -5.06B | -6.35B | -6.19B | -6.14B | -6.02B | -5.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$153.94B | 16.68 | 6.45% | 4.50% | -10.67% | 0.65% | |
72 Outperform | HK$187.84B | 16.48 | 9.82% | 4.54% | 2.02% | 51.27% | |
69 Neutral | HK$56.82B | 18.09 | 5.56% | 5.08% | 2.58% | 1.42% | |
68 Neutral | HK$97.54B | 6.06 | 12.76% | 5.89% | 1.42% | -10.32% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
64 Neutral | HK$135.47B | 23.00 | 9.73% | 4.94% | 0.36% | 2.55% | |
62 Neutral | HK$135.01B | 18.85 | 6.94% | 5.15% | -24.63% | 1.74% |